DOI QR코드

DOI QR Code

The Correlation of Dyspnea and Radiologic Quantity in Patients with COPD

만성폐쇄성폐질환 환자에서 호흡곤란과 영상학적 정량과의 상관관계

  • Jung, Eun Jung (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Kim, Yang Ki (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Lee, Young Mok (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Kim, Ki-Up (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Uh, Soo-Taek (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Kim, Yong Hoon (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Kim, Do Jin (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Park, Choon Sik (Division of Respiratory and Allergy Medicine, Soonchunhyang University Hospital, College of Medicine) ;
  • Hwang, Jung Hwa (Department of Radiology, Soonchunhyang University College of Medicine)
  • 정은정 (순천향대학교 의과대학 서울병원 내과학교실) ;
  • 김양기 (순천향대학교 의과대학 서울병원 내과학교실) ;
  • 이영목 (순천향대학교 의과대학 서울병원 내과학교실) ;
  • 김기업 (순천향대학교 의과대학 서울병원 내과학교실) ;
  • 어수택 (순천향대학교 의과대학 서울병원 내과학교실) ;
  • 김용훈 (순천향대학교 의과대학 천안병원 내과학교실) ;
  • 김도진 (순천향대학교 의과대학 부천병원 내과학교실) ;
  • 박춘식 (순천향대학교 의과대학 부천병원 내과학교실) ;
  • 황정화 (순천향대학교 의과대학 영상의학교실)
  • Received : 2009.03.04
  • Accepted : 2009.04.14
  • Published : 2009.04.30

Abstract

Background: A lung hyperinflation, or air trapping, caused by expiratory flow-limitation contributes to dyspnea in patients with chronic obstructive pulmonary disease (COPD). Forced expiratory volume in 1 second ($FEV_1$) has served as an important diagnostic measurement of COPD, but does not correlate with patient-centered outcomes such as dyspnea. Therefore, this study was performed to investigate the role of radiologic quantity in evaluating the dyspnea in patients with COPD by measuring lung hyperinflation in chest x-ray and high resolution chest tomography (HRCT). Methods: Fifty patients with COPD were enrolled in this study. Their subjective dyspnea score (modified Borg scale dyspnea index), spirometry, and lung volume were measured. Simultaneous hyperinflations of chest x-ray score ("chest score") and degree of emphysema of HRCT ("HRCT score") were measured. The "chest score" were composed of lung length, retrosternal space width, and height of the arc of the diaphragm and "HRCT score" were composed of severity and extent of emphysema. Results: The mean age of patients was 69 years old and their mean $FEV_1$ was 51.7%. The Borg score significantly correlated with parameters of spirometry and lung volume, including FVC, $FEV_1$, $FEV_1$/FVC, RV, RV/TLC, and DLCO. The Borg score correlated well with "HRCT score", but did not correlate with "chest score". Also, the Borg scale correlates inversely with body mass index. Conclusion: The quantity of emphysema on chest HRCT may serve as an objective marker of dyspnea in patients with COPD.

연구배경: COPD에서 보이는 호흡곤란의 주된 원인이 폐의 과팽창이고 이 과팽창을 치료하는 것이 호흡곤란의 향상에 중요한 것으로 밝혀지고 있다. 그러나 $FEV_1$, FVC만으로는 호흡곤란의 정도와 과팽창을 정확히 측정할 수 없다. 따라서 단순 흉부 방사선에서 관찰되는 폐의 과팽창의 정도와 고해상도흉부 단층촬영에서 폐기종의 정도가 호흡곤란을 객관적으로 알 수 있는 지표가 되는 지를 알아보고자 하였다. 방 법: COPD로 진단 받은 50명(평균 연령 69세, 남자 47명, 여자 3명)을 대상으로 하였다. 폐의 종축, 흉골 뒤공간, 횡격막의 높이를 각각 측정하여 총 0에서부터 3까지로 폐의 과팽창 정도(chest score)를 측정하였고, 고해상도 흉부단층 촬영에서 폐기종의 정도(HRCT score)를 구하여 이를 환자의 호흡곤란의 정도 및 폐용적 검사를 비롯한 폐기능 검사와의 상관관계를 구하였다. 결 과: 호흡곤란의 지수(Borg scale)는 폐기능 검사의 지표인 FVC, $FEV_1$, $FEV_1$/FVC, RV, RV/TLC, DLCO와 유의한 상관관계가 관찰되었다. Borg scale은 HRCT score와 상관관계가 있었으나, chest score와는 상관관계가 없었다. 그리고 Borg scale은 체질량 지수와 역 상관관계가 있었다. 결 론: 고해상도 흉부 단층촬영의 폐기종의 정도는 COPD 환자에서 호흡곤란의 정도를 알 수 있는 객관적 지표가 될 수 있다.

Keywords

References

  1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412 https://doi.org/10.1183/09031936.06.00025805
  2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504 https://doi.org/10.1016/S0140-6736(96)07492-2
  3. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7 https://doi.org/10.1164/rccm.200502-259OC
  4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76 https://doi.org/10.1164/ajrccm.163.5.2101039
  5. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993;148:1351-7 https://doi.org/10.1164/ajrccm/148.5.1351
  6. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:234-8 https://doi.org/10.1513/pats.200509-103SF
  7. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005;26:420-8 https://doi.org/10.1183/09031936.05.00136304
  8. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55 https://doi.org/10.1164/rccm.200703-456SO
  9. Celli BR. The importance of spirometry in COPD and asthma: effect on approach to management. Chest 2000;117:15S-9S https://doi.org/10.1378/chest.117.2_suppl.15S
  10. van Schayck CP. Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? Eur Respir J 2000;15:238-9 https://doi.org/10.1034/j.1399-3003.2000.15b02.x
  11. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:467-70 https://doi.org/10.1164/ajrccm/145.2_Pt_1.467
  12. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7:725-9 https://doi.org/10.1183/09031936.94.07040725
  13. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-36 https://doi.org/10.1164/ajrccm.152.3.7663792
  14. Pratt PC. Role of conventional chest radiography in diagnosis and exclusion of emphysema. Am J Med 1987;82:998-1006 https://doi.org/10.1016/0002-9343(87)90163-X
  15. Reich SB, Weinshelbaum A, Yee J. Correlation of radiographic measurements and pulmonary function tests in chronic obstructive pulmonary disease. AJR Am J Roentgenol 1985;144:695-9 https://doi.org/10.2214/ajr.144.4.695
  16. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81
  17. Expert panel on the identification, evaluation, and treatment of overweight in adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998;68:899-917
  18. Sakai F, Gamsu G, Im JG, Ray CS. Pulmonary function abnormalities in patients with CT-determined emphysema. J Comput Assist Tomogr 1987;11:963-8 https://doi.org/10.1097/00004728-198711000-00007
  19. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12 https://doi.org/10.1056/NEJMoa021322
  20. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434- 40 https://doi.org/10.1378/chest.121.5.1434
  21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152: S77-121
  22. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52 Suppl 5:S1-28
  23. Nicklaus TM, Stowell DW, Christiansen WR, Renzetti AD Jr. The accuracy of the roentgenologic diagnosis of chronic pulmonary emphysema. Am Rev Respir Dis 1966;93:889-99
  24. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162:1102-8 https://doi.org/10.1164/ajrccm.162.3.9907120
  25. Rothpearl A, Varma AO, Goodman K. Radiographic measures of hyperinflation in clinical emphysema. Discrimination of patients from controls and relationship to physiologic and mechanical lung function. Chest 1988;94:907-13 https://doi.org/10.1378/chest.94.5.907
  26. Boschetto P, Quintavalle S, Zeni E, Leprotti S, Potena A, Ballerin L, et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 2006;61:1037-42 https://doi.org/10.1136/thx.2006.058321
  27. Agust AG, Gari PG, Sauleda J, Busquets X. Weight loss in chronic obstructive pulmonary disease. Mechanisms and implications. Pulm Pharmacol Ther 2002;15:425-32 https://doi.org/10.1006/pupt.2002.0385
  28. Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1510-6 https://doi.org/10.1164/rccm.200504-595OC

Cited by

  1. The Survival Rate of Korean Patients with COPD with or without Acute Exacerbations vol.70, pp.6, 2009, https://doi.org/10.4046/trd.2011.70.6.474
  2. 단순 디지털 촬영과 저선량 CT의 폐기종 소견으로부터 폐쇄성 폐기능 장애 위험 비교 vol.71, pp.1, 2009, https://doi.org/10.4046/trd.2011.71.1.37